Alzheimer's disease (AD) is a progressive neurodegenerative disorder linked to dementia. Clinical diagnosis of AD occurs in the mid to advanced disease stages when patients exhibit signs of memory loss or dementia. Likewise, in AD experimental models, animals are assessed in the later stages when behavioral phenotypes are discernible.
Objectives
The goal of the current study was to investigate the encoding of temporal order recognition (TOR) tasks in the medial prefrontal cortex over a chronic duration before and during toxic or non-toxic amyloid-β (Aβ) lesioning (48 days).
Methods
The current study employs in vivo prefrontal cortex recording during TOR tasks to detect changes in putative pyramidal cell firing rates in naïve brains (baseline) and after toxic Aβ25−35 or control Aβ35−25 lesioning.
Results
TOR recognition index scores were positively correlated with putative unit change in firing rate (FR) during old object exploration intervals. Furthermore, the percentage distribution of putative units with increased FR during old object intervals was more than that of recent object intervals. Interestingly, in Aβ25−35 ensembles, the positive correlation between TOR performance and pyramidal FR was lost. In addition, there was a reduction in the percentage of units with increased FR during old object exploration. Interestingly, a positive correlation was observed between putative unit FR and recognition index scores in control Aβ35−25 ensembles.
Conclusions
Taken together, our results showed that toxic Aβ lesioning impacts TOR memory encoding by altering ensemble encoding patterns associated with object recognition and discrimination.
Tahami MonfaredAAByrnesMJWhiteLA, et al.Alzheimer's disease: epidemiology and clinical progression. Neurol Ther2022; 11: 553–569.
2.
SharpTCowenPJ. 5-HT And depression: is the glass half-full?Curr Opin Pharmacol2011; 11: 45–51.
3.
KramarowEATejada-VeraB. Dementia mortality in the United States, 2000-2017. Natl Vital Stat Rep2019; 68: 1–29.
4.
OgnibeneEMiddeiSDanieleS, et al.Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behav Brain Res2005; 156: 225–232.
5.
SalatDHKayeJAJanowskyJS. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol2001; 58: 1403–1408.
6.
YangXYaoCTianT, et al.A novel mechanism of memory loss in Alzheimer's disease mice via the degeneration of entorhinal-CA1 synapses. Mol Psychiatry2018; 23: 199–210.
7.
PrestonAREichenbaumH. Interplay of hippocampus and prefrontal cortex in memory. Curr Biol2013; 23: R764–R773.
8.
HatakeyamaTSugitaMYamadaK, et al.Temporal order memory of the rat in spontaneous object recognition: effects of number of items, exposure interval, and retention time. Learn Mem2018; 25: 574–579.
9.
AdelsteinTBKesnerRPStrassbergDS. Spatial recognition and spatial order memory in patients with dementia of the Alzheimer's type. Neuropsychologia1992; 30: 59–67.
10.
BellassenVIgloiKde SouzaLC, et al.Temporal order memory assessed during spatiotemporal navigation as a behavioral cognitive marker for differential Alzheimer's disease diagnosis. J Neurosci2012; 32: 1942–1952.
11.
HannessonDKHowlandJGPhillipsAG. Interaction between perirhinal and medial prefrontal cortex is required for temporal order but not recognition memory for objects in rats. J Neurosci2004; 24: 4596–4604.
12.
BarkerGRBirdFAlexanderV, et al.Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci2007; 27: 2948–2957.
13.
ChaoOYWangALNikolausS, et al.NK(3) receptor agonism reinstates temporal order memory in the hemiparkinsonian rat. Behav Brain Res2015; 285: 208–212.
14.
PardoMBeurelEJopeRS. Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome. Eur J Neurosci2017; 45: 490–498.
15.
BarkerGRIEvuarherheOWarburtonEC. Remembering the order of serially presented objects: a matter of time?Brain Neurosci Adv2019; 3: 2398212819883088.
16.
BaerendsESoudKFolkeJ, et al.Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native Abeta oligomers to rats. Acta Neuropathol Commun2022; 10: 113.
17.
KimHYLeeDKChungBR, et al.Intracerebroventricular injection of amyloid-beta peptides in normal mice to acutely induce Alzheimer-like cognitive deficits. J Vis Exp2016; 109: 53308.
18.
SatoKWakamiyaAMaedaT, et al.Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution. J Biochem1995; 118: 1108–1111.
19.
WeiGSheaJE. Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide. Biophys J2006; 91: 1638–1647.
20.
NaldiMFioriJPistolozziM, et al.Amyloid beta-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment. ACS Chem Neurosci2012; 3: 952–962.
21.
Cruz-SanchezADematagodaSAhmedR, et al.Developmental onset distinguishes three types of spontaneous recognition memory in mice. Sci Rep2020; 10: 10612.
22.
SwindaleNVMitelutCMurphyTH, et al.A visual guide to sorting electrophysiological recordings using ‘SpikeSorter’. J Vis Exp2017; 120: 55217.
23.
ChungJEMaglandJFBarnettAH, et al.A fully automated approach to spike sorting. Neuron2017; 95: 1381–1394.e1386.
24.
BarthoPHiraseHMonconduitL, et al.Characterization of neocortical principal cells and interneurons by network interactions and extracellular features. J Neurophysiol2004; 92: 600–608.
25.
Sotres-BayonFSierra-MercadoDPardilla-DelgadoE, et al.Gating of fear in prelimbic cortex by hippocampal and amygdala inputs. Neuron2012; 76: 804–812.
26.
MoormanDEAston-JonesG. Prefrontal neurons encode context-based response execution and inhibition in reward seeking and extinction. Proc Natl Acad Sci U S A2015; 112: 9472–9477.
27.
BreijyehZKaramanR. Comprehensive review on Alzheimer's disease: causes and treatment. Molecules2020; 25: 5789.
28.
KawasCHKimRCSonnenJA, et al.Multiple pathologies are common and related to dementia in the oldest-old: the 90+ study. Neurology2015; 85: 535–542.
29.
MayeuxRSternY. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med2012; 2: a006239.
30.
McKhannGMKnopmanDSChertkowH, et al.The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement2011; 7: 263–269.
31.
YaariRFleisherASTariotPN. Updates to diagnostic guidelines for Alzheimer's disease. Prim Care Companion CNS Disord2011; 13: PCC.11f01262.
32.
ParoniGBiscegliaPSeripaD. Understanding the amyloid hypothesis in Alzheimer's disease. J Alzheimers Dis2019; 68: 493–510.
33.
KametaniFHasegawaM. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer's disease. Front Neurosci2018; 12: 25.
34.
YiannopoulouKGPapageorgiouSG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis2020; 12: 1179573520907397.
35.
De-PaulaVJRadanovicMDinizBS, et al.Alzheimer's disease. Subcell Biochem2012; 65: 329–352.
36.
WestermanMACooper-BlacketerDMariashA, et al.The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci2002; 22: 1858–1867.
37.
AttiaHNAhmedKA. Protective role of functional food in cognitive deficit in young and senile rats. Behav Pharmacol2020; 31: 81–96.
38.
ChavanRSSupalkarKVSadarSS, et al.Animal models of Alzheimer's disease: an origin of innovative treatments and insight to the disease's etiology. Brain Res2023; 1814: 148449.
39.
FioritoJSaeedFZhangH, et al.Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease. Eur J Med Chem2013; 60: 285–294.
40.
PuzzoDPriviteraLPalmeriA. Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory. Neurobiol Aging2012; 33: 1484 e1415–1424.
41.
ShankarGMLiSMehtaTH, et al.Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med2008; 14: 837–842.
42.
WattersonDMGrum-TokarsVLRoySM, et al.Development of novel in vivo chemical probes to address CNS protein kinase involvement in synaptic dysfunction. PLoS One2013; 8: e66226.
43.
HiramatsuMTakiguchiONishiyamaA, et al.Cilostazol prevents amyloid beta peptide(25-35)-induced memory impairment and oxidative stress in mice. Br J Pharmacol2010; 161: 1899–1912.
44.
XiangJZBrownMW. Neuronal responses related to long-term recognition memory processes in prefrontal cortex. Neuron2004; 42: 817–829.
45.
SimonNWWoodJMoghaddamB. Action-outcome relationships are represented differently by medial prefrontal and orbitofrontal cortex neurons during action execution. J Neurophysiol2015; 114: 3374–3385.
46.
GralleMFerreiraST. Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol2007; 82: 11–32.
47.
ZussyCBrureauADelairB, et al.Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid beta fragment in rats. Am J Pathol2011; 179: 315–334.
48.
LuWRocheKW. Posttranslational regulation of AMPA receptor trafficking and function. Curr Opin Neurobiol2012; 22: 470–479.
49.
MakinoYJohnsonRCYuY, et al.Enhanced synaptic plasticity in mice with phosphomimetic mutation of the GluA1 AMPA receptor. Proc Natl Acad Sci U S A2011; 108: 8450–8455.
50.
MalenkaRCKauerJAZuckerRS, et al.Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science1988; 242: 81–84.
51.
LeeHKTakamiyaKHanJS, et al.Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory. Cell2003; 112: 631–643.
52.
SilvaAJStevensCFTonegawaS, et al.Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science1992; 257: 201–206.
53.
LamsaKIrvineEEGieseKP, et al.NMDA receptor-dependent long-term potentiation in mouse hippocampal interneurons shows a unique dependence on Ca(2+)/calmodulin-dependent kinases. J Physiol2007; 584: 885–894.
54.
LeeHKTakamiyaKHeK, et al.Specific roles of AMPA receptor subunit GluR1 (GluA1) phosphorylation sites in regulating synaptic plasticity in the CA1 region of hippocampus. J Neurophysiol2010; 103: 479–489.
55.
HayashiYShiSHEstebanJA, et al.Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science2000; 287: 2262–2267.
56.
ParkJHLeeSA. The fragility of temporal memory in Alzheimer's disease. J Alzheimers Dis2021; 79: 1631–1646.
57.
SagarHJCohenNJSullivanEV, et al.Remote memory function in Alzheimer's disease and Parkinson's disease. Brain1988; 111: 185–206.
58.
SullivanEVSagarHJ. Nonverbal recognition and recency discrimination deficits in Parkinson's disease and Alzheimer's disease. Brain1989; 112: 1503–1517.
